PGAM
WST icon

Princeton Global Asset Management’s West Pharmaceutical WST Stock Holding History

Princeton Global Asset Management’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$44.9K Hold
125
– – 0.01% 378
2026
Q1 		$31.3K Hold
125
– – 0.01% 417
2025
Q4 		$34.4K Sell
125
-75
-38% -$20.5K 0.01% 400
2025
Q3 		$52.5K Sell
200
-365
-65% -$88.7K 0.01% 314
2025
Q2 		$124K Sell
565
-425
-43% -$90.9K 0.02% 223
2025
Q1 		$222K Sell
990
-1,517
-61% -$418K 0.04% 178
2024
Q4 		$821K Sell
2,507
-100
-4% -$31.5K 0.15% 108
2024
Q3 		$783K Sell
2,607
-433
-14% -$133K 0.15% 107
2024
Q2 		$1M Buy
3,040
+299
+11% +$106K 0.22% 81
2024
Q1 		$1.08M Sell
2,741
-734
-21% -$272K 0.26% 76
2023
Q4 		$1.22M Hold
3,475
– – 0.31% 75
2023
Q3 		$1.3M Buy
3,475
+1,600
+85% +$619K 0.37% 71
2023
Q2 		$717K Sell
1,875
-1,600
-46% -$572K 0.21% 90
2023
Q1 		$1.2M Hold
3,475
– – 0.35% 72
2022
Q4 		$818K Hold
3,475
– – 0.26% 85
2022
Q3 		$855K Hold
3,475
– – 0.3% 79
2022
Q2 		$1.05M Sell
3,475
-75
-2% -$24.4K 0.34% 76
2022
Q1 		$1.46M Hold
3,550
– – 0.4% 70
2021
Q4 		$1.67M Sell
3,550
-150
-4% -$64.6K 0.47% 67
2021
Q3 		$1.57M Buy
3,700
+200
+6% +$84.3K 0.48% 64
2021
Q2 		$1.26M Hold
3,500
– – 0.38% 74
2021
Q1 		$986K Buy
3,500
+225
+7% +$64.4K 0.32% 85
2020
Q4 		$928K Hold
3,275
– – 0.32% 83
2020
Q3 		$900K Sell
3,275
-770
-19% -$204K 0.36% 79
2020
Q2 		$918K Hold
4,045
– – 0.29% 103
2020
Q1 		$616K Buy
4,045
+270
+7% +$41.6K 0.27% 105
2019
Q4 		$567K Buy
3,775
+250
+7% +$36.4K 0.23% 104
2019
Q3 		$493K Hold
3,525
– – 0.28% 98
2019
Q2 		$441K Hold
3,525
– – 0.26% 103
2019
Q1 		$388K Hold
3,525
– – 0.27% 96
2018
Q4 		$346K Buy
+3,525
New +$382K 0.31% 87

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Princeton Global Asset Management's WST Position: Q2 2026 in Review

Princeton Global Asset Management held its West Pharmaceutical (WST) position steady in Q2 2026 at 125 shares worth $44.9K. The position accounts for 0.01% of the portfolio, ranked #378.

Princeton Global Asset Management first reported a position in WST in Q4 2018 and has held it in 31 quarters since. The position peaked at $1.67M in Q4 2021. 834 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Princeton Global Asset Management held 125 shares of West Pharmaceutical worth $44.9K as of Q2 2026.
  • Princeton Global Asset Management left its West Pharmaceutical share count unchanged in Q2 2026.
  • West Pharmaceutical made up 0.01% of Princeton Global Asset Management's portfolio in Q2 2026, its #378 holding.
  • Princeton Global Asset Management first reported a position in West Pharmaceutical in Q4 2018 and has held it in 31 quarters since.
  • Princeton Global Asset Management's West Pharmaceutical position peaked at $1.67M in Q4 2021.
  • 834 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Princeton Global Asset Management's 13F filing for Q2 2026, filed 16 Jul 2026.